Important Information for Investors: Potential Recovery for Losses Suffered from Applied Therapeutics, Inc. (APLT)
New York, NY / ACCESS Newswire / February 10, 2025
If you are an investor in Applied Therapeutics, Inc. (NASDAQ: APLT) and have suffered losses as a result of alleged securities laws violations, you may be entitled to compensation. Zickler Harris PC, a leading securities law firm, is investigating potential claims on behalf of APLT investors. To learn more about the investigation and how you can potentially recover your losses, please follow this link:
Background on Applied Therapeutics, Inc.
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of rare and complex diseases. The company’s lead product candidate, AP-18, is a potential treatment for a rare genetic disorder known as Pompe disease. Applied Therapeutics went public through a reverse merger in 2022.
Investigation Overview
Zickler Harris PC is investigating potential securities laws violations by Applied Therapeutics, Inc. and certain of its executives and directors. The investigation concerns allegations that the company and its executives may have made false and misleading statements regarding the development and commercial prospects of AP-18, as well as the company’s financial condition.
Potential Impact on Individual Investors
If the investigation reveals that Applied Therapeutics, Inc. and its executives violated securities laws, investors may be able to recover their losses through a class action lawsuit. The investigation is ongoing, and it is important for investors to stay informed about any new developments. If you have suffered losses as a result of investing in APLT, you may be eligible to join the investigation and potentially recover your losses.
Potential Impact on the Industry and the World
The potential consequences of this investigation extend beyond Applied Therapeutics, Inc. and its investors. If the allegations are proven true, it could damage the reputation of the biopharmaceutical industry as a whole. It could also deter investors from putting their money into biotech companies, potentially slowing down the development and commercialization of new treatments for rare and complex diseases.
How to Participate in the Investigation
If you are an APLT investor and believe you may have losses, you can submit your information through the link below or contact Joseph E. Levi, Esq. directly:
- Website:
- Email: [email protected]
- Phone: (212) 344-0361
Conclusion
Investors in Applied Therapeutics, Inc. who have suffered losses as a result of alleged securities laws violations may be entitled to compensation. Zickler Harris PC is investigating the matter and encourages investors to submit their information to learn more about their potential recovery options. The potential consequences of this investigation extend beyond APLT and its investors, and it is important for the biopharmaceutical industry and the world to stay informed about any new developments.
If you have any questions or would like to discuss your potential recovery options, please contact Joseph E. Levi, Esq. at [email protected], (212) 344-0361, or through the submission form on the Zickler Harris PC website.
Stay informed and protect your investments. Contact Zickler Harris PC today.
